Skip to content

Clinical trials

Phase 1/2 Sarcoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sarcoma Phase: Phase 1/2 Country / region: United States Clear all

111 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20015
20022
20031
20061
20072
20082
20094
20102
20113
20123
20135
20143
20153
20167
20178
20183
20196
202011
20218
20225
20236
20242
20257
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50
Recruiting26
Terminated17
Active, not recruiting11
Unknown status3
Not yet recruiting2
Withdrawn1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)11
Eli Lilly and Company5
Fred Hutchinson Cancer Center4
Hutchmed3
M.D. Anderson Cancer Center3
Memorial Sloan Kettering Cancer Center3
Sarcoma Oncology Research Center, LLC3
Advenchen Pharmaceuticals, LLC.2
City of Hope Medical Center2
Massachusetts General Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sarcoma111
Breast Neoplasms18
Ovarian Neoplasms18
Melanoma17
Neoplasms16
Neoplasm Metastasis15
Colorectal Neoplasms14
Sarcoma, Ewing14
Carcinoma, Non-Small-Cell Lung13
Osteosarcoma13

Trials

Showing 1 to 25 of 111. Each trial links to its page on Pharma Observatory.

11 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.